S&P 5007,586-0.45%
NASDAQ25,982-0.78%
DOW52,093-0.63%
KOSPI6,680+0.79%
NIKKEI63,513+0.05%
STOXX 506,237-0.38%
GOLD$4,321-0.28%
SILVER$64.16+0.47%
OIL$105.22-0.58%
BTC$75,732-2.79%
ETH$2,399-4.55%
USDT$0.9994-0.05%
BNB$713.68-0.71%
XRP$1.29-9.23%
USDC$0.9997-0.02%
SOL$97.04-5.25%
TRX$0.3331-1.33%
FIGR_HELOC$1.00-2.42%
ZEC$1,118-3.77%
S&P 5007,586-0.45%
NASDAQ25,982-0.78%
DOW52,093-0.63%
KOSPI6,680+0.79%
NIKKEI63,513+0.05%
STOXX 506,237-0.38%
GOLD$4,321-0.28%
SILVER$64.16+0.47%
OIL$105.22-0.58%
BTC$75,732-2.79%
ETH$2,399-4.55%
USDT$0.9994-0.05%
BNB$713.68-0.71%
XRP$1.29-9.23%
USDC$0.9997-0.02%
SOL$97.04-5.25%
TRX$0.3331-1.33%
FIGR_HELOC$1.00-2.42%
ZEC$1,118-3.77%
GSK licenses Chinese firm’s cancer drug in US$750 million deal
British pharmaceutical giant GSK has agreed to acquire a cancer drug from Chinese firm Chimagen Biosciences in a deal worth up to US$750 million, underscoring China’s emergence as a global player in biotechnology. GSK announced plans on Tuesday to…
Indonesia's new finance minister faces an uphill battle on fiscal credibility
Indonesia's new finance minister faces an uphill battle on fiscal credibility CNBC
Neither tariffs nor export controls will stop China’s industrial engine
The first “China shock” was fairly easy to understand. Beginning in the 1990s, cheap Chinese goods poured into global markets, displacing large parts of lower-end manufacturing across the world. Now, China shock 2.0 seems to be under way, with China…
Bitcoin Suisse eyes Swiss job cuts, plans hub in Vietnam
Bitcoin Suisse eyes Swiss job cuts, plans hub in Vietnam Theinvestor